ATE319090T1 - Verwendung eines papillarfibroblast-spezifischen antikörpers als marker der hautqualität - Google Patents
Verwendung eines papillarfibroblast-spezifischen antikörpers als marker der hautqualitätInfo
- Publication number
- ATE319090T1 ATE319090T1 AT00403310T AT00403310T ATE319090T1 AT E319090 T1 ATE319090 T1 AT E319090T1 AT 00403310 T AT00403310 T AT 00403310T AT 00403310 T AT00403310 T AT 00403310T AT E319090 T1 ATE319090 T1 AT E319090T1
- Authority
- AT
- Austria
- Prior art keywords
- skin
- marker
- specific antibody
- skin quality
- papillary
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6881—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from skin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
- G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- G01N2400/38—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence, e.g. gluco- or galactomannans, e.g. Konjac gum, Locust bean gum, Guar gum
- G01N2400/40—Glycosaminoglycans, i.e. GAG or mucopolysaccharides, e.g. chondroitin sulfate, dermatan sulfate, hyaluronic acid, heparin, heparan sulfate, and related sulfated polysaccharides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/20—Dermatological disorders
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/971—Capture of complex after antigen-antibody reaction
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9915292A FR2801979B1 (fr) | 1999-12-03 | 1999-12-03 | Utilisation d'un anticorps specifique des fibroblastes papillaires comme marqueur de qualite d'une peau |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE319090T1 true ATE319090T1 (de) | 2006-03-15 |
Family
ID=9552884
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT00403310T ATE319090T1 (de) | 1999-12-03 | 2000-12-04 | Verwendung eines papillarfibroblast-spezifischen antikörpers als marker der hautqualität |
Country Status (8)
Country | Link |
---|---|
US (2) | US20010036642A1 (de) |
EP (1) | EP1111389B1 (de) |
JP (1) | JP3516263B2 (de) |
AT (1) | ATE319090T1 (de) |
CA (1) | CA2326713C (de) |
DE (1) | DE60026272T2 (de) |
ES (1) | ES2259599T3 (de) |
FR (1) | FR2801979B1 (de) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9969980B2 (en) * | 2001-09-21 | 2018-05-15 | Garnet Biotherapeutics | Cell populations which co-express CD49c and CD90 |
US9969977B2 (en) * | 2002-09-20 | 2018-05-15 | Garnet Biotherapeutics | Cell populations which co-express CD49c and CD90 |
EP2171043B1 (de) * | 2007-06-15 | 2015-03-18 | Garnet BioTherapeutics, Inc | Behandlung von krankheiten und störungen unter verwendung in vitro kultivierter und expandierter selbsterneuernder koloniebildender zellen |
US10837058B2 (en) | 2011-11-25 | 2020-11-17 | Chanel Parfums Beaute | Markers of papillary and reticular fibroblasts and uses thereof |
GB201721738D0 (en) * | 2017-12-22 | 2018-02-07 | King S College London | Method |
-
1999
- 1999-12-03 FR FR9915292A patent/FR2801979B1/fr not_active Expired - Fee Related
-
2000
- 2000-11-29 CA CA002326713A patent/CA2326713C/fr not_active Expired - Fee Related
- 2000-11-29 US US09/725,269 patent/US20010036642A1/en not_active Abandoned
- 2000-12-04 ES ES00403310T patent/ES2259599T3/es not_active Expired - Lifetime
- 2000-12-04 JP JP2000368860A patent/JP3516263B2/ja not_active Expired - Fee Related
- 2000-12-04 EP EP00403310A patent/EP1111389B1/de not_active Expired - Lifetime
- 2000-12-04 DE DE60026272T patent/DE60026272T2/de not_active Expired - Lifetime
- 2000-12-04 AT AT00403310T patent/ATE319090T1/de not_active IP Right Cessation
-
2003
- 2003-07-15 US US10/619,188 patent/US7192719B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US20040082016A1 (en) | 2004-04-29 |
JP3516263B2 (ja) | 2004-04-05 |
FR2801979B1 (fr) | 2002-02-08 |
DE60026272T2 (de) | 2006-11-23 |
CA2326713C (fr) | 2007-01-02 |
EP1111389A1 (de) | 2001-06-27 |
FR2801979A1 (fr) | 2001-06-08 |
JP2001215225A (ja) | 2001-08-10 |
US20010036642A1 (en) | 2001-11-01 |
DE60026272D1 (de) | 2006-04-27 |
ES2259599T3 (es) | 2006-10-16 |
EP1111389B1 (de) | 2006-03-01 |
US7192719B2 (en) | 2007-03-20 |
CA2326713A1 (fr) | 2001-06-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60324094D1 (de) | Verwendung einer proteinkinase a-inaktivierenden verbindung in einer kosmetisch verträglichen zusammensetzung zur aufhellung der haut | |
DE69836332D1 (de) | Benzyliden-1,3-dihydro-indol-2-on-derivate als inhibitoren von rezeptor tyrosine kinasesn, insbesondere von raf kinasen | |
AR008919A1 (es) | Anticuerpos anti-cd11a humanizados. | |
DE59709027D1 (de) | Verwendung von polymerisatdispersionen als bindemittel für dichtungs- oder beschichtungsmassen | |
BR0008239A (pt) | Processo de redução de crescimento de cabelos em mamìferos, uso de um inibidor de proteìna-tirosina quinase, processo de produção de uma composição para inibir o crescimento de cabelo de mamìferos, e, composição usada para inibir crescimento de cabelo em mamìferos | |
DE60122337D1 (de) | Verwendung von taci als antitumormittel | |
BRPI0503397A (pt) | composição de coloração, processo de coloração e uso de uma composição | |
DE69011329D1 (de) | Pdgf-alpha-rezeptor. | |
DE69214906D1 (de) | Homogene Immunotests unter Verwendung von Enzym-Inhibitoren | |
Schwarz et al. | Ascorbate induction of collagen synthesis as a means for elucidating a mechanism of quantitative control of tissue-specific function | |
DK1130394T3 (da) | In vitro-modeller af CNS-funktion og -dysfunktion | |
ATE166532T1 (de) | Anatomisches und biologisches konservierungsmittel und verbesserte einbalsamierungszusammensetzung und -verfahren | |
ATE319090T1 (de) | Verwendung eines papillarfibroblast-spezifischen antikörpers als marker der hautqualität | |
DE60107416D1 (de) | Adnf mischungen zur verbesserung der lernfähigkeit und der gedächtnisfunktion | |
BR9406223A (pt) | Método para determinar em uma amostra a atividade funcional de um componente da coagulação sanguinea método para diagnosticar um disturbio da coagulação/anticoagulação sanguinea preparado de anticorpo linhagem celular uso de fator v subunidades ou fragmentos do mesmo tendo atividade anticoagulante na forma de cofator par apc prepraro de plasma embalado plasma deficiente em atividade anticoagulante de fator v como cofator para apc uso do preparado de anticorpo preparado de proteina s preparado de | |
ATE227995T1 (de) | Verwendung von pseudopterosin zur förderung der wundheilung | |
ATE520024T1 (de) | Patch-clamp-verfahren und seine verwendung zur untersuchung subzellulärer merkmale | |
DE60003038D1 (de) | Chemokin bindendes protein von gammaherpesvirus 68 und verfahren zu seiner verwendung | |
ATA66189A (de) | Freitragender behaelter, insbesondere zur verwendung als elektrolysezelle | |
DE69229230D1 (de) | Antikörpertest zur erkennung von alkoholikern und zur überwachung der alkoholaufnahme | |
DE60035424D1 (de) | Neue enzyme und metabolite im skatol-stoffwechsel | |
DE60211461D1 (de) | Hautfärbemittel enthaltend ein Sorghumextrakt und Verwendung davon | |
Stoyanov et al. | Bulgaria· Ilko Stoyanov and Kristina Chakarova | |
DE59808166D1 (de) | Verwendung von 2-methyl-thiazolidin-2,4-dicarbonsäure als mukolytikum | |
DE60031963D1 (de) | Nachweis einer msrv-1 induzierten superantigenaktivität in einer biologischen probe |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |